EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy

David A Kalmbach, Jason C Ong, Philip Cheng, Anthony N Reffi, Leslie M Swanson, Mika Hirata, Grace M Seymour, Andrea S Castelan-Cuamatzi, Matthew B Jennings, D'Angela S Pitts, Andrea Roth, Thomas Roth und 1 weitere

Sleep Medicine · 2025

DOI: 10.1016/j.sleep.2025.106570 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sleep Medicine, 2025. Verfasst von David A Kalmbach und 12 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Roth Sleep Research & Disorders Center, Henry Ford Health, Detroit, MI, USA; Department of Obstetrics, Gynecology, and Reproductive Biology, M…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Pregnancy Complications, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Insomnia is common in pregnancy and fuels perinatal depression (PND). Cognitive-behavioral therapy for insomnia (CBTI) is effective during pregnancy, but unresolved cognitive arousal limits treatment outcomes. Enhancing reduction of cognitive arousal may improve patient outcomes. This randomized controlled trial (RCT) evaluated the effectiveness of CBTI and Perinatal Understanding of Mindful Awareness for Sleep (PUMAS, which combines mindfulness with behavioral sleep strategies) on insomnia, depression, and nocturnal cognitive arousal relative to sleep hygiene education (SHE). METHODS: A single-site, three-arm RCT of N = 64 pregnant women with clinically significant insomnia symptoms who received CBTI, PUMAS, or SHE. Active treatment was delivered via six weekly telemedicine video sessions. Outcomes included the insomnia severity index (ISI), Edinburgh postnatal depression scale (EPDS), and the pre-sleep arousal scale's cognitive factor (PSASC; nocturnal cognitive arousal). RESULTS: Over 95 % of active therapy patients completed ≥4 sessions, indicating high engagement. CBTI (ΔISI = -11.20 ± 6.93; 65.0 % insomnia remission) and PUMAS (ΔISI = -11.05 ± 3.84; 81.8 % insomnia remission) significantly alleviated insomnia relative to SHE (ΔISI = -4.50 ± 1.71; 13.6 % remission), which was replicated in women with comorbid OSA. PUMAS produced large reductions in PND and nocturnal cognitive arousal relative to SHE, whereas CBTI did not. Mediation analyses supported reducing cognitive arousal as a key mechanism by which PUMAS alleviated insomnia and PND. CONCLUSIONS: CBTI and PUMAS are effective for prenatal insomnia, even in women with comorbid OSA. PUMAS may be especially beneficial for pregnant women presenting with PND and/or high cognitive arousal (including perinatal rumination and worry), whereas CBTI may yield more modest benefits for these non-sleep outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersCognitive Behavioral TherapyPregnancy ComplicationsDepressionMindfulnessHumansFemalePregnancyAdultTelemedicineTreatment OutcomeArousal

Stichwörter der Autor:innen

COMISACognitive behavioral therapyMeditationPrenatalRuminationSleepWorry

Autor:innen und Institutionen

  • Thomas Roth Sleep Research & Disorders Center, Henry Ford Health, Detroit, MI, USA; Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University College of Human Medicine, East Lansing, MI,…
  • Nox Health, Suwanee, GA, USA.
  • Thomas Roth Sleep Research & Disorders Center, Henry Ford Health, Detroit, MI, USA.
  • Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
  • Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University College of Human Medicine, East Lansing, MI, USA; Maternal Fetal Medicine, Henry Ford Health, Detroit, MI, USA.
  • Thriving Minds Behavioral Health, Livonia, MI, USA.

Förderung

  • NIMH NIH HHS

Zitieren

APA

Kalmbach, D. A., Ong, J. C., Cheng, P., Reffi, A. N., Swanson, L. M., Hirata, M., Seymour, G. M., Castelan-Cuamatzi, A. S., Jennings, M. B., Pitts, D. S., Roth, A., Roth, T., & Drake, C. L. (2025). A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.106570

Vancouver

Kalmbach DA, Ong JC, Cheng P, Reffi AN, Swanson LM, Hirata M, et al. A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.106570

BibTeX
@article{Kalmbach2025,
  author = {Kalmbach, David A and Ong, Jason C and Cheng, Philip and Reffi, Anthony N and Swanson, Leslie M and Hirata, Mika and Seymour, Grace M and Castelan-Cuamatzi, Andrea S and Jennings, Matthew B and Pitts, D'Angela S and Roth, Andrea and Roth, Thomas and Drake, Christopher L},
  title = {A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy},
  journal = {Sleep Medicine},
  year = {2025},
  doi = {10.1016/j.sleep.2025.106570}
}
Kostenlos starten →